MET
The table below shows MetLife, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $17.09B | $14.60B | $13.72B | $13.04B | $12.35B | $11.64B |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$15.61B | -$11.49B | -$10.25B | -$2.62B | -$11.19B | -$18.57B |
| Dividends paid | $1.51B | $1.53B | $1.57B | $1.60B | $1.65B | $1.66B |
MetLife, Inc. reported operating cash flow of $17.09B for fiscal year 2025. That is up 17.1% from $14.60B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $14.77B (FY 2016) to $17.09B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $2.88B | $3.21B | $3.10B | $3.33B | $4.30B | $1.15B |
| Financing cash flow | $163.00M | -$3.13B | -$2.94B | -$9.95B | -$1.13B | $10.73B |